SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected, hospitalized COVID-19 patients

Mostrar otras versiones (1)

SARS-CoV-2, the causative agent of COVID-19, emerged at the end of 2019 and by mid-June 2020, the virus has spread to at least 215 countries, caused more than 8,000,000 confirmed infections and over 450,000 deaths, and overwhelmed healthcare systems worldwide. Like SARS-CoV, which emerged in 2002 an...

Descripción completa

Detalles Bibliográficos
Autores principales: Klimstra, William B., Tilston-Lunel, Natasha L., Nambulli, Sham, Boslett, James, McMillen, Cynthia M., Gilliland, Theron, Dunn, Matthew D., Sun, Chengqun, Wheeler, Sarah E, Wells, Alan, Hartman, Amy L., McElroy, Anita K., Reed, Douglas S., Rennick, Linda J., Duprex, W. Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325173/
https://www.ncbi.nlm.nih.gov/pubmed/32607507
http://dx.doi.org/10.1101/2020.06.19.154930

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325173/
https://www.ncbi.nlm.nih.gov/pubmed/32607507
http://dx.doi.org/10.1101/2020.06.19.154930

Ejemplares similares